This Is What Will Drive Moderna's Growth Over the Next Decade

Moderna (NASDAQ: MRNA) progressed from a clinical stage company to one selling a billion dollar product -- the coronavirus vaccine -- in just a year. But there is a lot more on the horizon for the biotech company. In this Motley Fool Live video recorded on May 28, 2021, Healthcare and Cannabis Bureau Editor and Analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss Moderna's investment strategy -- this year and into the future.

Continue reading

Source Fool.com